Supernus Pharmaceuticals (S49.F) Q3 2024 Earnings

Aug 6Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-0.27
0.05
0.38
0.71

Details

Expected EPS
0.3569514
Actual EPS
0.70562152752
Surprise EPS
0.35
Surprise Percent
+97.68%

Description

⁨Supernus Pharmaceuticals⁩ (⁦S49.F⁩) has reported earnings of ⁦0.70562152752⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts